Cancer Biomarkers

IMPACT FACTOR: 2,418 (JCR '10)

ISSN: 1574-0153
Volume 9-10; 12 issues
Institutional subscription (print and online) for 2011: €1144 / US$1465 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report: Last issue (volume 8:2) online on 6 September 2011
Next issue (volume 8:3) scheduled for October 2011

Aims and Scope
Editorial Board
Submission of Manuscripts
Abstracted in

Download flyer for this journal

Sudhir Srivastava PhD, MPH
c/o IOS Press, Inc.
4502 Rachael Manor Drive
Fairfax, VA 22032

Associate Editors
William E. Grizzle MD, PhD

Anna Lokshin PhD

Attila T. Lorincz PhD

Paola Muti MD

Harvey Pass MD

Tesshi Yamada MD, PhD

Statistical Editors
S. Baker
Rockville, MD, USA

Z. Feng
Seattle, WA, USA

M. Pepe
Seattle, WA, USA

S. Skates
Boston, MA, USA

Editorial Board
S. Belinsky, Albuquerque, NM, USA A.Y. Liu, Seattle, WA, USA
W.L. Bigbee, Pittsburg, PA, USA A. Lokshin, Pittsburgh, PA, USA
T. Block, Doylestown, PA, USA H.T. Lynch, Omaha, NE, USA
D. Brenner, Ann Arbor, MI, USA J. Marks, Durham, NC, USA
P. Cairns, Philadelphia, PA, USA S.J. Meltzer, Baltimore, MD, USA
D. Chan, Baltimore, MD, USA Y.-K. Paik, Seoul, Korea
D. Chia, Los Angeles, CA, USA H.I. Pass, New York, NY, USA
A.M. Chinnaiyan, Ann Arbor, MI, USA K. Rodland, Richland, WA, USA
B. Czerniak, Houston, TX, USA W.N. Rom, New York, NY, USA
M. Dizdaroglu, Gaithersburg, MD, USA H.K. Roy, Evanston, IL, USA
W.A. Franklin, Aurora, CO, USA J. Semmes, Norfolk, VA, USA
A. Gazdar, Dallas, TX, USA D. Sidransky, Baltimore, MD, USA
S. Hanash, Seattle, WA, USA S. Stass, Silver Spring, MD, USA
M. Hollingsworth, Omaha, NE, USA M.A. Tainsky, Detroit, MI, USA
A.M. Killary, Houston, TX, USA R. Zangar, Richland, WA, USA
J. LaBaer, Cambridge, MA, USA 

Submission of Manuscripts 
See instructions to authors.
Aims and Scope 
Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.
Abstracted in
Academic Source Complete, Academic Source Complete, CAB Abstracts, Chemical Abstracts Service (CAS), EMBIO, Journal Citation Reports/Science Edition, Prous Science Integrity, PubsHub, Science Citation Index-Expanded (SciSearch®), Ulrich's Periodicals Directory, ulrich's periodicals

IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019